ArticleScientific reports2013

Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection.

Chidchamai Kewcharoenwong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.